日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune Cell-Based versus Albumin-Based Ratios as Outcome Predictors in Critically Ill COVID-19 Patients

免疫细胞与白蛋白比值作为新冠肺炎危重症患者预后预测指标

Zeba, Snjezana; Surbatovic, Maja; Udovicic, Ivo; Stanojevic, Ivan; Vojvodic, Danilo; Rondovic, Goran; Mladenovic, Katarina; Abazovic, Tanja; Hasanovic, Almina; Ilic, Aleksandra N; Abazovic, Dzihan; Khan, Wasim; Djordjevic, Dragan

From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?

从细胞因子风暴到细胞因子微风:从免疫发病机制中吸取的教训是否改善了中重度 COVID-19 的免疫调节治疗?

Rondovic, Goran; Djordjevic, Dragan; Udovicic, Ivo; Stanojevic, Ivan; Zeba, Snjezana; Abazovic, Tanja; Vojvodic, Danilo; Abazovic, Dzihan; Khan, Wasim; Surbatovic, Maja

Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19

危重患者单核细胞和中性粒细胞功能的免疫监测:从脓毒症和/或创伤到新冠肺炎

Udovicic, Ivo; Stanojevic, Ivan; Djordjevic, Dragan; Zeba, Snjezana; Rondovic, Goran; Abazovic, Tanja; Lazic, Srdjan; Vojvodic, Danilo; To, Kendrick; Abazovic, Dzihan; Khan, Wasim; Surbatovic, Maja

Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia?

中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值、血小板与淋巴细胞比值以及平均血小板体积与血小板计数比值作为危重病和受伤患者的生物标志物:选择哪个比值来预测菌血症的预后和性质?

Djordjevic, Dragan; Rondovic, Goran; Surbatovic, Maja; Stanojevic, Ivan; Udovicic, Ivo; Andjelic, Tamara; Zeba, Snjezana; Milosavljevic, Snezana; Stankovic, Nikola; Abazovic, Dzihan; Jevdjic, Jasna; Vojvodic, Danilo